assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_000988065.1_ASM98806v1	NZ_CP011368	Mycoplasma canis strain LV, complete genome	1	165667-165772	1	CRISPRCasFinder	no		DEDDh,csn2,cas2,cas1,cas9,PD-DExK	Orphan	AATTTTTTGTCATTTTTTAACTCAT	25	0	0	NA	NA	NA	1	1	Orphan	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	NA|172aa|up_6|NZ_CP011368.1_157261_157777_+,NA|126aa|up_3|NZ_CP011368.1_161791_162169_+,NA|128aa|up_2|NZ_CP011368.1_162284_162668_+,NA|288aa|up_1|NZ_CP011368.1_162752_163616_+,NA|75aa|up_0|NZ_CP011368.1_163783_164008_-,NA|54aa|down_0|NZ_CP011368.1_166716_166878_-,NA|541aa|down_1|NZ_CP011368.1_167272_168895_-,NA|149aa|down_2|NZ_CP011368.1_168896_169343_-,NA|91aa|down_5|NZ_CP011368.1_194311_194584_-,NA|176aa|down_9|NZ_CP011368.1_201081_201609_+	NA|298aa|up_9|NZ_CP011368.1_154038_154932_+	pfam18144, SMODS, Second Messenger Oligonucleotide or Dinucleotide Synthetase domain	NA|174aa|up_8|NZ_CP011368.1_154903_155425_+	pfam18186, SLATT_4, SMODS and SLOG-associating 2TM effector domain family 4	NA|583aa|up_7|NZ_CP011368.1_155511_157260_+	pfam03235, DUF262, Protein of unknown function DUF262	NA|172aa|up_6|NZ_CP011368.1_157261_157777_+	NA	NA|422aa|up_5|NZ_CP011368.1_157872_159138_-	PRK12297, obgE, GTPase CgtA; Reviewed	NA|796aa|up_4|NZ_CP011368.1_159362_161750_+	PRK00390, leuS, leucyl-tRNA synthetase; Validated	NA|126aa|up_3|NZ_CP011368.1_161791_162169_+	NA	NA|128aa|up_2|NZ_CP011368.1_162284_162668_+	NA	NA|288aa|up_1|NZ_CP011368.1_162752_163616_+	NA	NA|75aa|up_0|NZ_CP011368.1_163783_164008_-	NA	NA|54aa|down_0|NZ_CP011368.1_166716_166878_-	NA	NA|541aa|down_1|NZ_CP011368.1_167272_168895_-	NA	NA|149aa|down_2|NZ_CP011368.1_168896_169343_-	NA	NA|119aa|down_3|NZ_CP011368.1_169344_169701_-	PHA02562, 46, endonuclease subunit; Provisional	NA|249aa|down_4|NZ_CP011368.1_192905_193652_-	COG0510, ycfN, Thiamine kinase and related kinases [Coenzyme transport and metabolism]	NA|91aa|down_5|NZ_CP011368.1_194311_194584_-	NA	NA|236aa|down_6|NZ_CP011368.1_194637_195345_-	pfam01863, DUF45, Protein of unknown function DUF45	NA|434aa|down_7|NZ_CP011368.1_195420_196722_-	pfam04973, NMN_transporter, Nicotinamide mononucleotide transporter	NA|604aa|down_8|NZ_CP011368.1_199053_200865_+	pfam02030, Lipoprotein_8, Hypothetical lipoprotein (MG045 family)	NA|176aa|down_9|NZ_CP011368.1_201081_201609_+	NA
GCF_000988065.1_ASM98806v1	NZ_CP011368	Mycoplasma canis strain LV, complete genome	2	379628-380851	2,1,1,2,3	CRISPRCasFinder,CRT,PILER-CR,PILER-CR,PILER-CR	no	csn2,cas2,cas1,cas9	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	Type II-A,Type II-B,Type II-C	GTTATTGTTTACCCAAATATTGTACAACACTAAAAC,NNNNNNGTTATTGTTTACCCAAATATTGTACAACACTAAAACN,GTTATTGTTTACCCAAATATTGTACAACACTAAAACA,GTTATTGTTTACCCAAATATTGTACAACACTAAAAC,TGTTATTGTTTACCCAAATATTGTACAACACTAAAAC	36,43,37,36,37	8	13	379664-379693|379664-379693|379730-379759|379730-379759|380324-380353|380456-380485|380456-380485|380588-380617|379731-379759|379731-379759|380456-380484|380456-380484|380588-380616	NZ_CP011368.1_285412-285383|NZ_CP011368.1_904350-904379|NZ_CP011368.1_896115-896086|NZ_CP011368.1_293644-293673|NZ_CP011368.1_933279-933308|NZ_CP011368.1_904242-904271|NZ_CP011368.1_285520-285491|NZ_CP011368.1_290417-290446|NZ_CP011368.1_293645-293673|NZ_CP011368.1_896114-896086|NZ_CP011368.1_285520-285492|NZ_CP011368.1_904242-904270|NZ_CP011368.1_290417-290445	NA:NA:NA:NA:NA	18,18,12,12,12	18	TypeII-A,TypeII-B,TypeII-C	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	NA|926aa|up_5|NZ_CP011368.1_369131_371909_-,NA|132aa|up_2|NZ_CP011368.1_376835_377231_+,csn2|252aa|down_1|NZ_CP011368.1_383400_384156_-,NA|355aa|down_6|NZ_CP011368.1_389969_391034_+	NA|817aa|up_9|NZ_CP011368.1_363074_365525_-	COG4608, AppF, ABC-type oligopeptide transport system, ATPase component [Amino acid transport and metabolism]	NA|354aa|up_8|NZ_CP011368.1_365517_366579_-	COG0444, DppD, ABC-type dipeptide/oligopeptide/nickel transport system, ATPase component [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|438aa|up_7|NZ_CP011368.1_366588_367902_-	COG1173, DppC, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|395aa|up_6|NZ_CP011368.1_367882_369067_-	COG0601, DppB, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|926aa|up_5|NZ_CP011368.1_369131_371909_-	NA	NA|609aa|up_4|NZ_CP011368.1_371932_373759_-	cd09608, M3B_PepF, Peptidase family M3B, oligopeptidase F (PepF)	NA|844aa|up_3|NZ_CP011368.1_374232_376764_+	PRK12903, secA, preprotein translocase subunit SecA; Reviewed	NA|132aa|up_2|NZ_CP011368.1_376835_377231_+	NA	NA|540aa|up_1|NZ_CP011368.1_377296_378916_+	PRK15064, PRK15064, ABC transporter ATP-binding protein; Provisional	NA|226aa|up_0|NZ_CP011368.1_378915_379593_+	PRK11713, PRK11713, 16S ribosomal RNA methyltransferase RsmE; Provisional	NA|391aa|down_0|NZ_CP011368.1_381026_382199_-	COG2826, Tra8, Transposase and inactivated derivatives, IS30 family [DNA replication, recombination, and repair]	csn2|252aa|down_1|NZ_CP011368.1_383400_384156_-	NA	cas2|110aa|down_2|NZ_CP011368.1_384158_384488_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|293aa|down_3|NZ_CP011368.1_384474_385353_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|1234aa|down_4|NZ_CP011368.1_385484_389186_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	NA|184aa|down_5|NZ_CP011368.1_389330_389882_+	PRK02230, PRK02230, inorganic pyrophosphatase; Provisional	NA|355aa|down_6|NZ_CP011368.1_389969_391034_+	NA	NA|276aa|down_7|NZ_CP011368.1_391063_391891_-	PRK01060, PRK01060, endonuclease IV; Provisional	NA|367aa|down_8|NZ_CP011368.1_391883_392984_-	pfam07885, Ion_trans_2, Ion channel	NA|324aa|down_9|NZ_CP011368.1_393031_394003_-	COG1609, PurR, Transcriptional regulators [Transcription]
GCF_000988065.1_ASM98806v1	NZ_CP011368	Mycoplasma canis strain LV, complete genome	3	382295-383385	3,2,4	CRISPRCasFinder,CRT,PILER-CR	no	csn2,cas2,cas1,cas9	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	Type II-A,Type II-B,Type II-C	GTTATTGTTTACCCAAATATTGTACAACACTAAAAC,GTTATTGTTTACCCAAATATTGTACAACACTAAAAC,GTTATTGTTTACCCAAATATTGTACAACACTAAAAC	36,36,36	2	3	382661-382690|383320-383349|383320-383349	NZ_CP011368.1_932921-932892|NZ_CP011368.1_909356-909385|NZ_CP011368.1_931508-931537	NA:NA:NA	16,16,15	16	TypeII-A,TypeII-B,TypeII-C	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	NA|926aa|up_6|NZ_CP011368.1_369131_371909_-,NA|132aa|up_3|NZ_CP011368.1_376835_377231_+,csn2|252aa|down_0|NZ_CP011368.1_383400_384156_-,NA|355aa|down_5|NZ_CP011368.1_389969_391034_+,NA|63aa|down_9|NZ_CP011368.1_396120_396309_-	NA|354aa|up_9|NZ_CP011368.1_365517_366579_-	COG0444, DppD, ABC-type dipeptide/oligopeptide/nickel transport system, ATPase component [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|438aa|up_8|NZ_CP011368.1_366588_367902_-	COG1173, DppC, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|395aa|up_7|NZ_CP011368.1_367882_369067_-	COG0601, DppB, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|926aa|up_6|NZ_CP011368.1_369131_371909_-	NA	NA|609aa|up_5|NZ_CP011368.1_371932_373759_-	cd09608, M3B_PepF, Peptidase family M3B, oligopeptidase F (PepF)	NA|844aa|up_4|NZ_CP011368.1_374232_376764_+	PRK12903, secA, preprotein translocase subunit SecA; Reviewed	NA|132aa|up_3|NZ_CP011368.1_376835_377231_+	NA	NA|540aa|up_2|NZ_CP011368.1_377296_378916_+	PRK15064, PRK15064, ABC transporter ATP-binding protein; Provisional	NA|226aa|up_1|NZ_CP011368.1_378915_379593_+	PRK11713, PRK11713, 16S ribosomal RNA methyltransferase RsmE; Provisional	NA|391aa|up_0|NZ_CP011368.1_381026_382199_-	COG2826, Tra8, Transposase and inactivated derivatives, IS30 family [DNA replication, recombination, and repair]	csn2|252aa|down_0|NZ_CP011368.1_383400_384156_-	NA	cas2|110aa|down_1|NZ_CP011368.1_384158_384488_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|293aa|down_2|NZ_CP011368.1_384474_385353_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|1234aa|down_3|NZ_CP011368.1_385484_389186_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	NA|184aa|down_4|NZ_CP011368.1_389330_389882_+	PRK02230, PRK02230, inorganic pyrophosphatase; Provisional	NA|355aa|down_5|NZ_CP011368.1_389969_391034_+	NA	NA|276aa|down_6|NZ_CP011368.1_391063_391891_-	PRK01060, PRK01060, endonuclease IV; Provisional	NA|367aa|down_7|NZ_CP011368.1_391883_392984_-	pfam07885, Ion_trans_2, Ion channel	NA|324aa|down_8|NZ_CP011368.1_393031_394003_-	COG1609, PurR, Transcriptional regulators [Transcription]	NA|63aa|down_9|NZ_CP011368.1_396120_396309_-	NA
GCF_000988065.1_ASM98806v1	NZ_CP011368	Mycoplasma canis strain LV, complete genome	4	612960-613041	4	CRISPRCasFinder	no		DEDDh,csn2,cas2,cas1,cas9,PD-DExK	Orphan	GGTGGTTGAGGTGTGGGTTTTGGTTCTT	28	0	0	NA	NA	NA	1	1	Orphan	DEDDh,csn2,cas2,cas1,cas9,PD-DExK	NA|354aa|up_6|NZ_CP011368.1_598645_599707_+,NA|418aa|up_2|NZ_CP011368.1_603865_605119_+,NA|412aa|down_1|NZ_CP011368.1_619289_620525_-,NA|619aa|down_3|NZ_CP011368.1_631014_632871_-,NA|200aa|down_4|NZ_CP011368.1_633021_633621_-,NA|51aa|down_7|NZ_CP011368.1_654605_654758_-	NA|380aa|up_9|NZ_CP011368.1_592518_593658_+	PRK05250, PRK05250, S-adenosylmethionine synthetase; Validated	NA|1348aa|up_8|NZ_CP011368.1_593799_597843_+	cd08586, PI-PLCc_BcPLC_like, Catalytic domain of Bacillus cereus phosphatidylinositol-specific phospholipases C and similar proteins	NA|173aa|up_7|NZ_CP011368.1_597889_598408_-	pfam00358, PTS_EIIA_1, phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 1	NA|354aa|up_6|NZ_CP011368.1_598645_599707_+	NA	NA|391aa|up_5|NZ_CP011368.1_599990_601163_+	COG2826, Tra8, Transposase and inactivated derivatives, IS30 family [DNA replication, recombination, and repair]	NA|373aa|up_4|NZ_CP011368.1_601563_602682_+	TIGR02349, Chaperone_protein_DnaJ, chaperone protein DnaJ	NA|328aa|up_3|NZ_CP011368.1_602750_603734_+	PRK05425, PRK05425, asparagine synthetase AsnA; Provisional	NA|418aa|up_2|NZ_CP011368.1_603865_605119_+	NA	NA|1653aa|up_1|NZ_CP011368.1_605118_610077_+	COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]	NA|384aa|up_0|NZ_CP011368.1_610160_611312_+	PHA02517, PHA02517, putative transposase OrfB; Reviewed	NA|1975aa|down_0|NZ_CP011368.1_613363_619288_-	pfam07555, NAGidase, beta-N-acetylglucosaminidase	NA|412aa|down_1|NZ_CP011368.1_619289_620525_-	NA	NA|1625aa|down_2|NZ_CP011368.1_626100_630975_+	PRK07133, PRK07133, DNA polymerase III subunits gamma and tau; Validated	NA|619aa|down_3|NZ_CP011368.1_631014_632871_-	NA	NA|200aa|down_4|NZ_CP011368.1_633021_633621_-	NA	NA|384aa|down_5|NZ_CP011368.1_633757_634909_-	PHA02517, PHA02517, putative transposase OrfB; Reviewed	NA|771aa|down_6|NZ_CP011368.1_651291_653604_+	pfam09028, Mac-1, Mac 1	NA|51aa|down_7|NZ_CP011368.1_654605_654758_-	NA	NA|2475aa|down_8|NZ_CP011368.1_657531_664956_-	pfam00754, F5_F8_type_C, F5/8 type C domain	NA|353aa|down_9|NZ_CP011368.1_665259_666318_+	cd01092, APP-like, Similar to Prolidase and Aminopeptidase P
